Skip to main content
SpringerLink
Log in

Vascular Engineering of Blood Coagulation

  • Chapter
  • First Online:
Vascular Engineering

Abstract

Blood coagulation and platelet play crucial role in the maintenance of homeostasis in vascular system. Majority of major players and their roles in hemostasis and thrombus formation are known in details, but mostly qualitatively. For stabling the new concept of “Vascular Engineering”, quantitative biological experiments and new technology of “Computer Simulation” will be helpful.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Agnelli G, Buller HR, Cohen A, Curto M, Gallus AS, Johnson M, Masiukiewicz U, Pak R, Thompson J, Raskob GE, Weitz JI, Investigators A (2013a) Oral apixaban for the treatment of acute venous thromboembolism. N Engl J Med 369:799–808

    Article  CAS  PubMed  Google Scholar 

  • Agnelli G, Buller HR, Cohen A, Curto M, Gallus AS, Johnson M, Porcari A, Raskob GE, Weitz JI, Investigators P-E. (2013b) Apixaban for extended treatment of venous thromboembolism. N Engl J Med 368:699–708

    Article  CAS  PubMed  Google Scholar 

  • Alexander JH, Lopes RD, James S, Kilaru R, He Y, Mohan P, Bhatt DL, Goodman S, Verheugt FW, Flather M, Huber K, Liaw D, Husted SE, Lopez-Sendon J, De Caterina R, Jansky P, Darius H, Vinereanu D, Cornel JH, Cools F, Atar D, Leiva-Pons JL, Keltai M, Ogawa H, Pais P, Parkhomenko A, Ruzyllo W, Diaz R, White H, Ruda M, Geraldes M, Lawrence J, Harrington RA, Wallentin L, Investigators A- (2011) Apixaban with antiplatelet therapy after acute coronary syndrome. N Engl J Med 365:699–708

    Article  CAS  PubMed  Google Scholar 

  • Angiolillo DJ, Capodanno D, Goto S (2010) Platelet thrombin receptor antagonism and atherothrombosis. Eur Heart J 31:17–28

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, Pogue J, Reilly PA, Themeles E, Varrone J, Wang S, Alings M, Xavier D, Zhu J, Diaz R, Lewis BS, Darius H, Diener HC, Joyner CD, Wallentin L, Committee R-LS, Investigators (2009) Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 361:1139–1151

    Article  CAS  PubMed  Google Scholar 

  • Connolly SJ, Eikelboom J, Joyner C, Diener HC, Hart R, Golitsyn S, Flaker G, Avezum A, Hohnloser SH, Diaz R, Talajic M, Zhu J, Pais P, Budaj A, Parkhomenko A, Jansky P, Commerford P, Tan RS, Sim KH, Lewis BS, Van Mieghem W, Lip GY, Kim JH, Lanas-Zanetti F, Gonzalez-Hermosillo A, Dans AL, Munawar M, O’Donnell M, Lawrence J, Lewis G, Afzal R, Yusuf S, Committee AS, Investigators (2011) Apixaban in patients with atrial fibrillation. N Engl J Med 364:806–817

    Article  CAS  PubMed  Google Scholar 

  • Eikelboom JW, Connolly SJ, Brueckmann M, Granger CB, Kappetein AP, Mack MJ, Blatchford J, Devenny K, Friedman J, Guiver K, Harper R, Khder Y, Lobmeyer MT, Maas H, Voigt JU, Simoons ML, Van de Werf F, Investigators R-A (2013) Dabigatran versus warfarin in patients with mechanical heart valves. N Engl J Med 369:1206–1214

    Article  CAS  PubMed  Google Scholar 

  • Eriksson BI, Borris LC, Friedman RJ, Haas S, Huisman MV, Kakkar AK, Bandel TJ, Beckmann H, Muehlhofer E, Misselwitz F, Geerts W, Group RS (2008) Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty. N Engl J Med 358:2765–2775

    Article  CAS  PubMed  Google Scholar 

  • Giugliano RP, Ruff CT, Braunwald E, Murphy SA, Wiviott SD, Halperin JL, Waldo AL, Ezekowitz MD, Weitz JI, Spinar J, Ruzyllo W, Ruda M, Koretsune Y, Betcher J, Shi M, Grip LT, Patel SP, Patel I, Hanyok JJ, Mercuri M, Antman EM, Investigators EA-T (2013) Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med 369:2093–2104

    Article  CAS  PubMed  Google Scholar 

  • Goto S (2001) Role of von willebrand factor for the onset of arterial thrombosis. Clin Lab 47:327–334

    CAS  PubMed  Google Scholar 

  • Goto S (2004) Understanding the mechanism and prevention of arterial occlusive thrombus formation by anti-platelet agents. Curr Med Chem Cardiovasc Hematol Agents 2:149–156

    Article  CAS  PubMed  Google Scholar 

  • Goto S (2005) Cilostazol: potential mechanism of action for antithrombotic effects accompanied by a low rate of bleeding. Atheroscler Suppl 6:3–11

    Article  CAS  PubMed  Google Scholar 

  • Goto S (2008) Blood constitution: platelet aggregation, bleeding, and involvement of leukocytes. Rev Neurol Dis 5(Suppl 1):S22–S27

    PubMed  Google Scholar 

  • Goto S (2012) Monitoring of the effects of new-generation oral anticoagulants – what does it mean? Circ J Off J Jpn Circ Soc 76:596–597

    CAS  Google Scholar 

  • Goto S, Tomita A (2014) New antithrombotics for secondary prevention of acute coronary syndrome. Clin Cardiol 37:178–187

    Article  PubMed  Google Scholar 

  • Goto S, Salomon DR, Ikeda Y, Ruggeri ZM (1995) Characterization of the unique mechanism mediating the shear-dependent binding of soluble von willebrand factor to platelets. J Biol Chem 270:23352–23361

    Article  CAS  PubMed  Google Scholar 

  • Goto S, Ikeda Y, Saldivar E, Ruggeri ZM (1998) Distinct mechanisms of platelet aggregation as a consequence of different shearing flow conditions. J Clin Invest 101:479–486

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Goto S, Tamura N, Eto K, Ikeda Y, Handa S (2002) Functional significance of adenosine 5′-diphosphate receptor (p2y(12)) in platelet activation initiated by binding of von willebrand factor to platelet gp ibalpha induced by conditions of high shear rate. Circulation 105:2531–2536

    Article  CAS  PubMed  Google Scholar 

  • Goto S, Tamura N, Li M, Handa M, Ikeda Y, Handa S, Ruggeri ZM (2003) Different effects of various anti-gpiib-iiia agents on shear-induced platelet activation and expression of procoagulant activity. J Thromb Haemost JTH 1:2022–2030

    Article  CAS  PubMed  Google Scholar 

  • Granger CB, Alexander JH, McMurray JJ, Lopes RD, Hylek EM, Hanna M, Al-Khalidi HR, Ansell J, Atar D, Avezum A, Bahit MC, Diaz R, Easton JD, Ezekowitz JA, Flaker G, Garcia D, Geraldes M, Gersh BJ, Golitsyn S, Goto S, Hermosillo AG, Hohnloser SH, Horowitz J, Mohan P, Jansky P, Lewis BS, Lopez-Sendon JL, Pais P, Parkhomenko A, Verheugt FW, Zhu J, Wallentin L, Committees A, Investigators (2011) Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 365:981–992

    Article  CAS  PubMed  Google Scholar 

  • Hagihara M, Higuchi A, Tamura N, Ueda Y, Hirabayashi K, Ikeda Y, Kato S, Sakamoto S, Hotta T, Handa S, Goto S (2004) Platelets, after exposure to a high shear stress, induce il-10-producing, mature dendritic cells in vitro. J Immunol 172:5297–5303

    Article  CAS  PubMed  Google Scholar 

  • Hokusai VTEI, Buller HR, Decousus H, Grosso MA, Mercuri M, Middeldorp S, Prins MH, Raskob GE, Schellong SM, Schwocho L, Segers A, Shi M, Verhamme P, Wells P (2013) Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism. N Engl J Med 369:1406–1415

    Article  Google Scholar 

  • Hoshiba Y, Hatakeyama K, Tanabe T, Asada Y, Goto S (2006) Co-localization of von willebrand factor with platelet thrombi, tissue factor and platelets with fibrin, and consistent presence of inflammatory cells in coronary thrombi obtained by an aspiration device from patients with acute myocardial infarction. J Thromb Haemost JTH 4:114–120

    Article  CAS  PubMed  Google Scholar 

  • Hoyer LW (1994) Hemophilia a. N Engl J Med 330:38–47

    Article  CAS  PubMed  Google Scholar 

  • Ikeda Y, Handa M, Murata M, Goto S (2000) A new approach to antiplatelet therapy: Inhibitor of gpib/v/ix-vwf interaction. Haemostasis 30(Suppl 3):44–52

    CAS  PubMed  Google Scholar 

  • Kawamura Y, Takahari Y, Tamura N, Eguchi Y, Urano T, Ishida H, Goto S (2009) Imaging of structural changes in endothelial cells and thrombus formation at the site of fecl(3)-induced injuries in mice cremasteric arteries. J Atheroscler Thromb 16:807–814

    Article  CAS  PubMed  Google Scholar 

  • Mateen FJ, Shuaib A (2007) Progress in clinical neurosciences: the ‘antiplatelet’ agents and the role of the endothelium. Can J Neurol Sci Le journal canadien des sciences neurologiques 34:270–279

    Article  Google Scholar 

  • Mega JL, Braunwald E, Wiviott SD, Bassand JP, Bhatt DL, Bode C, Burton P, Cohen M, Cook-Bruns N, Fox KA, Goto S, Murphy SA, Plotnikov AN, Schneider D, Sun X, Verheugt FW, Gibson CM, Investigators AAT (2012) Rivaroxaban in patients with a recent acute coronary syndrome. N Engl J Med 366:9–19

    Article  CAS  PubMed  Google Scholar 

  • Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W, Breithardt G, Halperin JL, Hankey GJ, Piccini JP, Becker RC, Nessel CC, Paolini JF, Berkowitz SD, Fox KA, Califf RM, Investigators RA (2011) Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 365:883–891

    Article  CAS  PubMed  Google Scholar 

  • Ruggeri ZM (2007) Von willebrand factor: looking back and looking forward. Thromb Haemost 98:55–62

    CAS  PubMed  Google Scholar 

  • Schulman S, Kearon C, Kakkar AK, Mismetti P, Schellong S, Eriksson H, Baanstra D, Schnee J, Goldhaber SZ, Group R-CS (2009) Dabigatran versus warfarin in the treatment of acute venous thromboembolism. N Engl J Med 361:2342–2352

    Article  CAS  PubMed  Google Scholar 

  • Tamura N, Kitajima I, Kawamura Y, Toda E, Eguchi Y, Ishida H, Goto S (2009) Important regulatory role of activated platelet-derived procoagulant activity in the propagation of thrombi formed under arterial blood flow conditions. Circ J Off J Jpn Circ Soc 73:540–548

    CAS  Google Scholar 

  • Tomita A, Tamura N, Nanazawa Y, Shiozaki S, Goto S (2014) Development of virtual platelets implementing the functions of three platelet membrane proteins with different adhesive characteristics. J Atheroscler Thromb 22:201–210

    Article  PubMed  Google Scholar 

  • Yamashita A, Sumi T, Goto S, Hoshiba Y, Nishihira K, Kawamoto R, Hatakeyama K, Date H, Imamura T, Ogawa H, Asada Y (2006) Detection of von willebrand factor and tissue factor in platelets-fibrin rich coronary thrombi in acute myocardial infarction. Am J Cardiol 97:26–28

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine (Cardiology), Tokai University School of Medicine, 143 Shimokasuya, Isehara, Kanagawa, 259-1193, Japan

    Shinya Goto

Authors
  1. Shinya Goto
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shinya Goto .

Editor information

Editors and Affiliations

  1. Waseda University, Tokyo, Tokyo, Japan

    Kazuo Tanishita

  2. The University of Tokyo, Tokyo, Tokyo, Japan

    Kimiko Yamamoto

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer Japan

About this chapter

Cite this chapter

Goto, S. (2016). Vascular Engineering of Blood Coagulation. In: Tanishita, K., Yamamoto, K. (eds) Vascular Engineering. Springer, Tokyo. https://doi.org/10.1007/978-4-431-54801-0_11

Download citation

  • DOI: https://doi.org/10.1007/978-4-431-54801-0_11

  • Published:

  • Publisher Name: Springer, Tokyo

  • Print ISBN: 978-4-431-54800-3

  • Online ISBN: 978-4-431-54801-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation